Vor Bio (VOR) announced the appointment of Adi Osovsky, S.J.D. as General Counsel. Dr. Osovsky brings 17 years of corporate counsel and law firm experience in the biotechnology and pharmaceutical sectors. Dr. Osovsky joins Vor Bio from iTeos Therapeutics (ITOS), where she served as Executive Vice President, Head of Legal & Corporate Secretary.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VOR:
- Vor Biopharma Appoints Sarah Reed to Board
- Vor Biopharma Files Prospectus for $119.7M Stock Sale
- Vor Bio’s telitacicept achieved primary endpoint in Phase 3 study
- Largest borrow rate increases among liquid names
- Positive Phase 3 Results and Strong Financial Position Support Buy Rating for Vor Biopharma